{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T03:57:18Z","timestamp":1780631838655,"version":"3.54.1"},"reference-count":55,"publisher":"Informa UK Limited","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Expert Review of Vaccines"],"published-print":{"date-parts":[[2008,11]]},"DOI":"10.1586\/14760584.7.9.1309","type":"journal-article","created":{"date-parts":[[2008,11,4]],"date-time":"2008-11-04T05:19:45Z","timestamp":1225775985000},"page":"1309-1320","source":"Crossref","is-referenced-by-count":13,"title":["Kinrix\u2122: a new combination DTaP\u2013IPV vaccine for children aged 4\u20136 years"],"prefix":"10.1586","volume":"7","author":[{"given":"Wayde M","family":"Weston","sequence":"first","affiliation":[{"name":"GlaxoSmithKline Biologicals, 2301 Renaissance Boulevard, RN0220, King of Prussia, PA 19406, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola P","family":"Klein","sequence":"additional","affiliation":[{"name":"Kaiser Permanente Vaccine Study Center, Oakland, CA, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2014,1,9]]},"reference":[{"key":"e_1_3_2_3_1","unstructured":"Edwards KM Decker MD. Pertussis vaccine. In: Vaccines (5th Edition) . Plotkin SA Orenstein WA Offitt P (Eds). Saunders PA USA 471\u2013528 (2008)."},{"key":"e_1_3_2_4_1","first-page":"1","volume":"41","year":"1992","unstructured":"Centers for Disease Control and Prevention. Pertussis vaccination: acellular pertussis vaccine for reinforcing and booster use \u2013 supplementary ACIP statement. Recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR Recomm. Rep.41(RR-1), 1\u201310 (1992).","journal-title":"MMWR Recomm. Rep."},{"key":"e_1_3_2_5_1","doi-asserted-by":"crossref","unstructured":"Plotkin SA Vidor E. Poliovirus vaccine-inactivated. In: Vaccines (5th Edition) . Plotkin SA Orenstein WA Offitt P (Eds). Saunders PA USA 605\u2013630 (2008).","DOI":"10.1016\/B978-1-4160-3611-1.50029-5"},{"key":"e_1_3_2_6_1","doi-asserted-by":"crossref","unstructured":"Sutter RW Kew OM Cochi SL. Poliovirus vaccine-live. In: Vaccines (5th Edition) . Plotkin SA Orenstein WA Offitt P (Eds). Saunders PA USA 631\u2013686 (2008).","DOI":"10.1016\/B978-1-4160-3611-1.50030-1"},{"key":"e_1_3_2_7_1","first-page":"720","volume":"43","year":"1994","unstructured":"Centers for Disease Control and Prevention. Certification of poliomyelitis eradication \u2013 the Americas, 1994. MMWR43(39), 720\u2013722 (1994).","journal-title":"MMWR"},{"key":"e_1_3_2_8_1","first-page":"35","volume":"46","year":"1997","unstructured":"Centers for Disease Control and Prevention. Recommended childhood immunization schedule \u2013 United States, 1997. MMWR46(2), 35\u201340 (1997).","journal-title":"MMWR"},{"key":"e_1_3_2_9_1","first-page":"1","volume":"49","author":"Prevots","year":"2000","unstructured":"Prevots DR, Burr RK, Sutter RW et al. Advisory Committee on Immunization Practices. Poliomyelitis prevention in the United States. Updated recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recom. Rep.49(RR-5), 1\u201322 (2000).","journal-title":"MMWR Recom. Rep."},{"key":"e_1_3_2_10_1","first-page":"Q1","volume":"55","year":"2006","unstructured":"Centers for Disease Control and Prevention. Recommended immunization schedules for persons aged 0\u201318 years \u2013 United States, 2007. MMWR55(51\u201352), Q1\u2013Q4 (2006).","journal-title":"MMWR"},{"key":"e_1_3_2_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ypmed.2004.12.001"},{"key":"e_1_3_2_12_1","first-page":"574","volume":"51","year":"2002","unstructured":"Centers for Disease Control and Prevention. Notice to readers: food and drug administration approval of a fifth acellular pertussis vaccine for use among infants and young children \u2013 United States, 2002. MMWR51(26), 574 (2002).","journal-title":"MMWR"},{"key":"e_1_3_2_13_1","doi-asserted-by":"publisher","DOI":"10.1080\/00365540410020884"},{"key":"e_1_3_2_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2005.12.009"},{"key":"e_1_3_2_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2006.04.001"},{"key":"e_1_3_2_16_1","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0b013e3181616180"},{"key":"e_1_3_2_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2006.05.017"},{"key":"e_1_3_2_18_1","first-page":"574","volume":"55","year":"2006","unstructured":"Centers for Disease Control and Prevention. General recommendations on immunization. Recommendations of the Advisory Committee on Immunization Practices (ACIP), US; 2006. MMWR Recomm. Rep.55(RR-15), 574 (2006).","journal-title":"MMWR Recomm. Rep."},{"key":"e_1_3_2_19_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1996.03530250041024"},{"key":"e_1_3_2_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(96)70152-X"},{"key":"e_1_3_2_21_1","doi-asserted-by":"publisher","DOI":"10.1099\/00222615-25-4-279"},{"key":"e_1_3_2_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-1157(83)80038-9"},{"key":"e_1_3_2_23_1","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.20.4.772-774.1984"},{"key":"e_1_3_2_24_1","doi-asserted-by":"crossref","unstructured":"Wharton M Vitek CR. Diphtheria toxoid. In: Vaccines (5th Edition) . Plotkin SA Orenstein WA Offitt P (Eds). Saunders PA USA 211\u2013228 (2008).","DOI":"10.1016\/B978-1-4160-3611-1.50014-3"},{"key":"e_1_3_2_25_1","unstructured":"World Health Organization. Standard procedure for determining immunity to poliovirus using the microneutralization test. WHO\/EPI\/Gen93.9. Geneva Switzerland (1993)."},{"key":"e_1_3_2_26_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02097184"},{"key":"e_1_3_2_27_1","unstructured":"Food and Drug Administration Center for Biologics Evaluation and Research. Open session on adult pertussis. Presented at: Proceedings of a Vaccines and Related Products Advisory Committee . Bethesda MD USA 5 June 1997."},{"key":"e_1_3_2_28_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199602083340601"},{"key":"e_1_3_2_29_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.106.4.e51"},{"key":"e_1_3_2_30_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.96.3.592"},{"key":"e_1_3_2_31_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2005-1217"},{"key":"e_1_3_2_32_1","first-page":"1","volume":"49","year":"2000","unstructured":"Centers for Disease Control and Prevention. Use of diphtheria toxoid\u2013tetanus toxoid\u2013acellular pertussis vaccine as a five-dose series. Supplemental recommendations if the Advisory Committee on Immunization Practices (ACIP). MMWR49(RR\u201313), 1\u20138 (2000).","journal-title":"MMWR"},{"key":"e_1_3_2_33_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.105.1.e12"},{"key":"e_1_3_2_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(01)00230-4"},{"key":"e_1_3_2_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2007.04.056"},{"key":"e_1_3_2_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(97)70247-6"},{"key":"e_1_3_2_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1045-1870(03)00033-5"},{"key":"e_1_3_2_38_1","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.73.12.8130-8135.2005"},{"key":"e_1_3_2_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2005.02.030"},{"key":"e_1_3_2_40_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.112.6.e453"},{"key":"e_1_3_2_41_1","first-page":"1","volume":"25","author":"Rennels","year":"2008","unstructured":"Rennels M, Black S, Woo E et al. Safety of a fifth dose of diphtheria and tetanus toxoid and acellular pertussis vaccine in children experiencing extensive, local reactions to the fourth dose. Pediatr. Infect. Dis. J.25(5), 1\u20132 (2008).","journal-title":"Pediatr. Infect. Dis. J."},{"key":"e_1_3_2_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2006.09.053"},{"key":"e_1_3_2_43_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.inf.0000190028.96152.46"},{"key":"e_1_3_2_44_1","first-page":"1","volume":"46","year":"1997","unstructured":"Centers for Disease Control. Pertussis vaccination: use of acellular pertussis vaccines among infants and young children recommendations of the advisory committee on immunization practices (ACIP). MMWR Recomm. Rep.46(RR-7), 1\u201325 (1997).","journal-title":"MMWR Recomm. Rep."},{"key":"e_1_3_2_45_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2006-0114"},{"key":"e_1_3_2_46_1","first-page":"506","volume":"13","author":"Happe","year":"2007","unstructured":"Happe LE, Lunacsek OE, Marshall GS et al. Combination vaccine use and vaccination quality in a managed care population. Am. J. Manag. Care13(9), 506\u2013512 (2007).","journal-title":"Am. J. Manag. Care"},{"key":"e_1_3_2_47_1","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0b013e31805d7f17"},{"key":"e_1_3_2_48_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.inf.0000222413.47344.23"},{"key":"e_1_3_2_49_1","first-page":"137","volume":"81","year":"2006","unstructured":"World Health Organization. Inactivated poliovirus vaccine following oral poliovirus vaccine cessation. Supplement to the WHO position paper. Wkly Epidemiol. Rec.81, 137\u2013144 (2006).","journal-title":"Wkly Epidemiol. Rec."},{"key":"e_1_3_2_50_1","first-page":"1","volume":"55","author":"Broder","year":"2004","unstructured":"Broder KR, Cortese MM, Iskander JK et al. Preventing tetanus, diphtheria, and pertussis among adolescents: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm. Rep.55(RR-3), 1\u201334 (2004).","journal-title":"MMWR Recomm. Rep."},{"key":"e_1_3_2_51_1","first-page":"1","volume":"55","author":"Kretsinger","year":"2006","unstructured":"Kretsinger K, Broder KR, Cortese MM et al. Preventing tetanus, diphtheria, and pertussis among adults: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine recommendations of the Advisory Committee on Immunization Practices (ACIP) and recommendation of ACIP, supported by the Healthcare Infection Control Practices Advisory Committee (HICPAC), for use of Tdap among health-care personnel. MMWR Recomm. Rep.55(RR-17), 1\u201337 (2006).","journal-title":"MMWR Recomm. Rep."},{"key":"e_1_3_2_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jadohealth.2005.08.009"},{"key":"e_1_3_2_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(03)00496-1"},{"key":"e_1_3_2_54_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00431-006-0403-x"},{"key":"e_1_3_2_55_1","first-page":"21","volume":"3","year":"2006","unstructured":"Robert Koch-Institut: Empfehlung der St\u00e4ndigen Impfkommission (STIKO) am Robert Koch-Institut zur Pertussis-Schutzimpfung. Epidemiologisches Bulletin3, 21\u201323 (2006).","journal-title":"Epidemiologisches Bulletin"},{"key":"e_1_3_2_56_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2007.05.012"},{"key":"e_1_3_2_57_2_1","unstructured":"NHS Routine childhood immunization programme. January 2008 www.immunisation.nhs.uk\/immunisation_schedule (Accessed 5 May 2008)"}],"container-title":["Expert Review of Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1586\/14760584.7.9.1309","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T09:58:20Z","timestamp":1756720700000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1586\/14760584.7.9.1309"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11]]},"references-count":55,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2008,11]]}},"alternative-id":["10.1586\/14760584.7.9.1309"],"URL":"https:\/\/doi.org\/10.1586\/14760584.7.9.1309","relation":{},"ISSN":["1476-0584","1744-8395"],"issn-type":[{"value":"1476-0584","type":"print"},{"value":"1744-8395","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,11]]}}}